Sven Dethlefs, EVP Global Marketing&Portfolio at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 606 shares at $10.86 ($7K) on 2021-03-03, disclosed to the SEC on 2021-03-04.
Scheduled sale ($7k) by EVP Global Marketing&Portfolio under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TEVA | SELL | 2022-03-08 | $132K | — | Filing → |
| TEVA | SELL | 2022-03-02 | $40K | — | Filing → |
| TEVA | SELL | 2022-02-10 | $37K | — | Filing → |